Ariad Pharmaceuticals

3 Biotechs Still Burning Through Cash
Motley Fool
Tue, 03/5/13 - 10:44 am
Ariad Pharmaceuticals
MannKind
Dynavax
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
It's Hard to Make Money When FDA Approvals Are Priced In
Motley Fool
Mon, 12/17/12 - 09:31 am
FDA
drug approvals
Ariad Pharmaceuticals
Novartis
Dendreon
Medivation
Bayer
ONYX Pharmaceuticals
Otsuka
Bristol-Myers Squibb
Why Ariad Pharmaceuticals' Shares Dropped
Motley Fool
Sat, 12/15/12 - 11:30 am
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
leukemia
acute lymphoblastic leukemia
Ariad Sinks on Safety Warnings With U.S. Drug Approval
Bloomberg
Sat, 12/15/12 - 11:25 am
Ariad Pharmaceuticals
Iclusig
leukemia
acute lymphoblastic leukemia
chronic myeloid leukemia
Ariad Wins Approval for Drug to Treat Rare Leukemias, FDA Says
Bloomberg
Fri, 12/14/12 - 12:31 pm
Ariad Pharmaceuticals
FDA
chronic myeloid leukemia
Iclusig
Small-Cap Biotechs That Could Make Big Moves This Week
Seeking Alpha
Mon, 12/10/12 - 12:06 pm
Star Scientific
Acadia
Alexza
Santarus
Sarepta
Ariad Pharmaceuticals
ARIAD Announces 12-Month Data from Pivotal PACE Trial of Ponatinib in Heavily Pretreated Chronic-Phase CML Patients
Yahoo/BusinessWire
Sun, 12/9/12 - 01:16 pm
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Ariad's on the Launchpad
Motley Fool
Thu, 11/8/12 - 10:51 am
Ariad Pharmaceuticals
earnings
3 Things to Watch at Ariad Pharmaceuticals
Motley Fool
Tue, 10/16/12 - 10:38 am
Ariad Pharmaceuticals
Ponatinib
ridaforolimus
AP1903
AP26113
Here are 5 Biopharmaceutical Companies on the Rise
Wall St Cheat Street
Sat, 10/13/12 - 11:55 am
Pluristem
Ariad Pharmaceuticals
Sarepta Therapeutics
Amicus Therapeutics
StemCells
5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
Seeking Alpha
Tue, 10/9/12 - 04:21 pm
PLX
Pluristem Therapeutics
Ariad Pharmaceuticals
Ponatinib
Sarepta
eteplirsen
Fabry's disease
Amicus Therapeutics
StemCells
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Seeking Alpha
Mon, 10/1/12 - 11:27 am
Ponatinib
CML
Ariad Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Novartis
This Stock Rocks as Its Drug Rolls Ahead
Motley Fool
Sat, 09/29/12 - 12:11 pm
Ariad Pharmaceuticals
Ponatinib
chronic myelogenous leukemia
leukemia
ARIAD Presents Initial Clinical Proof-of-Concept of AP26113 in Patients with Non-Small Cell Lung Cancer at ESMO 2012 Congress
Yahoo/BusinessWire
Sat, 09/29/12 - 12:02 pm
non-small cell lung cancer
Ariad Pharmaceuticals
AP26113
FDA Makes This Biotech Less Risky
Motley Fool
Thu, 09/20/12 - 10:59 am
FDA
Ariad Pharmaceuticals
Ariad Pharmaceuticals Gearing Up For Ponatinib's Approval
Seeking Alpha
Wed, 08/29/12 - 05:54 pm
Ariad Pharmaceuticals
Ponatinib
Pfizer
Bristol-Myers Squibb
Novartis
ARIAD Begins Phase 1/2 Trial of Ponatinib in Japan
Yahoo
Mon, 08/20/12 - 10:33 am
Ariad Pharmaceuticals
Japan
Ponatinib
Six Disruptive Biotech Stocks
Motley Fool
Sat, 08/18/12 - 03:51 pm
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals

Pages